Feedback

Stereotactic Radiosurgery/ Stereotactic Body Radiation Treatment for Lung Cancer

Hiran C. Fernando, MB, FRCS, Arjun Pennathur, MD, FACS
Stereotactic Radiosurgery/ Stereotactic Body Radiation Treatment for Lung Cancer is a topic covered in the Pearson's General Thoracic.

To view the entire topic, please or .

STS Cardiothoracic Surgery E-Book from The Society of Thoracic Surgeons provides expert guidance for Cardiac and Thoracic Surgery. Sections include Pearson’s General Thoracic, Esphageal, Adult Cardiac, and Pediatric and Congenital Cardiac Surgery. Explore these free sample topics:

-- The first section of this topic is shown below --

Introduction

Stereotactic radiosurgery (SRS) is an approach to radiation therapy utilizing multiple convergent beams, precise localization with a stereotactic coordinate system, rigid immobilization, and single-fraction treatment.[1] Extracranial SRS is also referred to as stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR), and these terms are used interchangeably in this chapter. [2],[3] The application of SRS/SBRT/SABR to tumors in the thorax may offer an alternative to surgery in the management of patients with lung neoplasm.[4],[5],[6],[7],[8],[9]

Lung cancer is the most common cancer with nearly 2 million cases a year globally, and is the leading cause of death by cancer.[10],[11] Annually, 225,000 new cases of lung cancer are diagnosed in the United States and an estimated 158,000 Americans are expected to die from lung cancer, accounting for approximately 27% of all cancer deaths.[12] In this chapter, we will the review how SBRT differs from external beam radiotherapy (EBR), and how SBRT has evolved. In addition, we will review the use of SBRT to treat lung cancer covering potential indications for SBRT, patient selection, the results of SBRT treatment, and quality of life after treatment. SBRT treatment of a variety of lung neoplasms, including primary non-small cell lung cancer (NSCLC), recurrent lung cancer, persistent cancer in a previously irradiated field, and pulmonary metastases, will be discussed.

-- To view the remaining sections of this topic, please or --

Introduction

Stereotactic radiosurgery (SRS) is an approach to radiation therapy utilizing multiple convergent beams, precise localization with a stereotactic coordinate system, rigid immobilization, and single-fraction treatment.[1] Extracranial SRS is also referred to as stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR), and these terms are used interchangeably in this chapter. [2],[3] The application of SRS/SBRT/SABR to tumors in the thorax may offer an alternative to surgery in the management of patients with lung neoplasm.[4],[5],[6],[7],[8],[9]

Lung cancer is the most common cancer with nearly 2 million cases a year globally, and is the leading cause of death by cancer.[10],[11] Annually, 225,000 new cases of lung cancer are diagnosed in the United States and an estimated 158,000 Americans are expected to die from lung cancer, accounting for approximately 27% of all cancer deaths.[12] In this chapter, we will the review how SBRT differs from external beam radiotherapy (EBR), and how SBRT has evolved. In addition, we will review the use of SBRT to treat lung cancer covering potential indications for SBRT, patient selection, the results of SBRT treatment, and quality of life after treatment. SBRT treatment of a variety of lung neoplasms, including primary non-small cell lung cancer (NSCLC), recurrent lung cancer, persistent cancer in a previously irradiated field, and pulmonary metastases, will be discussed.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: December 22, 2020